Effects of bladder training and/or tolterodine in female patients with overactive bladder syndrome: A prospective, randomized study

Journal of Korean Medical Science

Volumn 21, Issue 6, 2006, Pages 1060-1063

  Song, Cheryn ^a   Park, Jun Tag ^b   Kyeong, Ok Heo ^a   Kyu, Sung Lee ^c   Choo, Myung Soo ^a  

^a University of Ulsan College of Medicine   (South Korea)

^b Seoul Adventist Hospital   (South Korea)

^c Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

Bladder training; Overactive bladder; Tolterodine; Urinary incontinence

Indexed keywords

EID: 33845876955     PISSN: 10118934     EISSN: 15986357     Source Type: Journal    
DOI: 10.3346/jkms.2006.21.6.1060     Document Type: Article

References (20)

1. Milsom I, Abrams P, Cardozo L, Roberts RG, Thuroff J, Wein AJ. How widespread are the symptoms of an overactive bladder and how are they managed? A population-based prevalence study. BJU Int 2001; 87: 760-6.
2. Stewart WF, Van Rooyen JB, Cundiff GW, Abrams P, Herzog AR, Corey R, Hunt TL, Wein AJ. Prevalence and burden of overactive bladder in the United States. World J Urol 2003; 20: 327-36.
3. Blok BF, Holstege G. The central control of micturition and continence: implications for urology. BJU Int 1999; 83: 1-6.
4. Igawa Y. Discussion: functional role of M1, M2, and M3 muscarinic receptors in overactive bladder. Urology 2000; 55: 47-50.
5. 1- adrenoreceptor antagonists. BJU Int 2000; 85: 1-5.
6. Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U, Van Kerrebroeck P, Victor A, Wein A, Standardisation Subcommittee of the International Continence Society. The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society. Neurourol Urodyn 2002; 21: 167-78.
7. Artibani W. Diagnosis and significance of idiopathic overactive bladder. Urology 1997; 50: 25-32.
8. Frewen WK. The management of urgency and frequency of micturition. Br J Urol 1982; 52: 367-9.
9. Elder DD, Stephenson TP. An assessment of the Frewen regime in the treatment of detrusor dysfunction in females. Br J Urol 1980; 52: 467-71.
10. Bo K, Berghmans LC. Nonpharmacologic treatments for overactive bladder-pelvic floor exercises. Urology 2000; 55: 7-11.
11. Burgio KL, Locher JL, Goode PS, Hardin JM, McDowell BJ, Dombrowski M, Candib D. Behavioral vs drug treatment for urge urinary incontinence in older women: a randomized controlled trial. JAMA 1998; 280: 1995-2000.
12. Godec C, Cass AS, Ayala GF. Bladder inhibition with functional electrical stimulation. Urology 1975; 6: 663-6.
13. Jeffcoate TN, Francis WJ. Urgency incontinence in the female. Am J Obstet Gynecol 1966; 94: 604-18.
14. Pengelly AW, Booth CM. A prospective trial of bladder training as treatment for detrusor instability. Br J Urol 1980; 52: 463-6.
15. Holmes DM, Stone AR, Bary PR, Richards CJ, Stephenson TP. Bladder training-3 years on. Br J Urol 1983; 55: 660-4.
16. Jarvis GJ. A controlled trial of bladder drill and drug therapy in the management of detrusor instability. Br J Urol 1981; 53: 565-6.
17. Millard RJ. Clinical efficacy of tolterodine with or without a simplified pelvic floor exercise regimen. Neurourol Urodyn 2004; 23: 48-53.
18. Mattiasson A, Blaakaer J, Hoye K, Wein AJ, Tolterodine Scandinavian Study Group. Simplified bladder training augments the effectiveness of tolterodine in patients with an overactive bladder. BJU Int 2003; 91: 54-60.
19. Messelink EJ. Treatment of the overactive bladder with tolterodine, a new muscarinic receptor antagonist. BJU Int 1999; 83: 48-52.
20. Appell RA. Clinical efficacy and safety of tolterodine in the treatment of overactive bladder: a pooled analysis. Urology 1997; 50: 90-6.